This year hasn’t been easy. As we adapt to a new way of living and shift our means of interaction virtually, we wanted to make sure we were still able to provide you with the best updates in research, education and all-things type 1 diabetes (T1D). So we launched Let’s Talk T1D!
During the week of November 2nd, delegates joined JDRF for its annual Kids for a Cure Program. This year, due to COVID the event was held virtually.
For many families newly diagnosed with type 1 diabetes (T1D), few words instill as much fear as Halloween. A whole holiday centered on candy can be a lot for families to handle. However, with the right tools and attitude, Halloween can be just as fun for someone with T1D as it is for any other goblin or ghoul.
Here are some helpful tips for having a T1D scare-free Halloween.
In case you missed out or need to catch up on where our efforts stand on our campaign to demand affordable and accessible diabetes technologies for everyone with T1D, here’s a summary of key developments.
Prince Edward Island resident and JDRF advocate Brooks Roche is getting vocal about #AccessForAll.
Back to school includes a lot more than just a backpack, notebooks, and a pencil case. Getting back into the school routine requires a lot of preparation and planning for kids who live with type 1 diabetes (T1D)
I want to tell you a little bit about my resilient wife, Audrey.
The Yukon government has made the decision to fully fund flash glucose monitors (Flash GMs) for those 18 years of age and older with type 1 diabetes (T1D) starting on October 1st.
As 2021 draws near, we move closer to an important milestone that changed and aided the type 1 diabetes (T1D) community in an enormous way – the 100th year of insulin.
There’s good news for pumpers in BC! BC Pharmacare has added YpsoPump by YpsoMed to its Tier 1 list of approved insulin pumps. BC residents with type 1 diabetes of all ages can now choose between the Omnipod by Insulet or the YpsoPump under the province’s pump program.
JDRF’s attention has been focused on Canada’s west coast increasingly as the BC government inches closer to a decision on whether or not to cover continuous glucose monitoring (CGM) and flash glucose monitoring (FGM) systems. BC Pharmacare commissioned a health technology assessment on these technologies more than a year ago but the results have yet to be released.
A recent increase in type 1 diabetes (T1D) diagnoses in children under 18 in some hospitals in north-west London, UK, has triggered news stories that COVID-19 could cause the disease in children. But experts have stressed that the locally reported increase in diagnoses is not yet clearly linked to the pandemic.
-300x300.jpg)
